ValuEngine upgraded shares of Mazor Robotics (NASDAQ:MZOR) from a hold rating to a buy rating in a research note released on Friday.

MZOR has been the topic of a number of other research reports. Zacks Investment Research lowered Mazor Robotics from a hold rating to a sell rating in a research note on Wednesday, July 18th. BidaskClub lowered Mazor Robotics from a hold rating to a sell rating in a research note on Saturday, May 26th. Cantor Fitzgerald assumed coverage on Mazor Robotics in a research note on Thursday, May 31st. They issued a neutral rating and a $57.00 target price on the stock. Needham & Company LLC reiterated a sell rating on shares of Mazor Robotics in a research note on Thursday, August 2nd. Finally, Wells Fargo & Co increased their target price on Mazor Robotics from $56.00 to $62.00 and gave the stock a market perform rating in a research note on Tuesday, May 15th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The company has an average rating of Hold and an average target price of $61.08.

MZOR stock traded down $0.05 during midday trading on Friday, reaching $47.64. The company’s stock had a trading volume of 174,225 shares, compared to its average volume of 408,816. Mazor Robotics has a 1 year low of $41.60 and a 1 year high of $76.56. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of -95.28 and a beta of 1.51.

Mazor Robotics (NASDAQ:MZOR) last released its earnings results on Thursday, August 2nd. The medical instruments supplier reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.13). Mazor Robotics had a negative return on equity of 7.17% and a negative net margin of 12.80%. The business had revenue of $13.20 million during the quarter, compared to analysts’ expectations of $17.02 million. During the same quarter in the previous year, the business earned ($0.05) EPS. The business’s revenue for the quarter was down 14.8% on a year-over-year basis. equities research analysts forecast that Mazor Robotics will post -0.12 earnings per share for the current fiscal year.

Several institutional investors have recently made changes to their positions in the company. ProVise Management Group LLC increased its stake in shares of Mazor Robotics by 8.7% during the first quarter. ProVise Management Group LLC now owns 12,311 shares of the medical instruments supplier’s stock valued at $755,000 after buying an additional 982 shares during the period. Atria Investments LLC increased its stake in shares of Mazor Robotics by 26.8% during the second quarter. Atria Investments LLC now owns 5,312 shares of the medical instruments supplier’s stock valued at $295,000 after buying an additional 1,122 shares during the period. Nepsis Inc. increased its stake in shares of Mazor Robotics by 1.4% during the second quarter. Nepsis Inc. now owns 102,560 shares of the medical instruments supplier’s stock valued at $5,693,000 after buying an additional 1,408 shares during the period. Eagle Global Advisors LLC increased its stake in shares of Mazor Robotics by 11.5% during the second quarter. Eagle Global Advisors LLC now owns 14,500 shares of the medical instruments supplier’s stock valued at $805,000 after buying an additional 1,500 shares during the period. Finally, Carnegie Capital Asset Management LLC increased its stake in shares of Mazor Robotics by 7.8% during the second quarter. Carnegie Capital Asset Management LLC now owns 20,660 shares of the medical instruments supplier’s stock valued at $950,000 after buying an additional 1,500 shares during the period. Hedge funds and other institutional investors own 26.13% of the company’s stock.

Mazor Robotics Company Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

Featured Article: Average Daily Trade Volume – ADTV

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.